Nucleome Therapeutics logo

Nucleome Therapeutics Employee Directory

Biotechnology ResearchEngland, United Kingdom51-200 Employees

Nucleome Therapeutics has about 54 employees across 2 continents, most of them in Europe. By country, the largest groups are United Kingdom Of Great Britain And Northern Ireland (92%), Netherlands (4%) and Spain (2%). Biotechnology and Entrepreneurship make up over half of the profiles with a known department. Nucleome Therapeutics's workforce spans 11 departments.

Find Nucleome Therapeutics employees' phone numbers or email addresses

Nucleome Therapeutics Global Highlights

Location
Employees

Europe
49

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    46
  • Netherlands
    2
  • Spain
    1

North America
1

Minus sign iconPlus sign icon
  • United States Of America
    1

Europe accounts for 98% of Nucleome Therapeutics's workforce, followed by North America (2%).

Nucleome Therapeutics's Leadership

  • Chief Executive Officer at Nucleome Therapeutics
    M. B.
    Chief Executive Officer
  • Cso At Nucleome Therapeutics at Nucleome Therapeutics
    S. H.
    Cso At Nucleome Therapeutics
  • Chief Technology Officer at Nucleome Therapeutics
    J. W.
    Chief Technology Officer
  • Chief Scientific Officer at Nucleome Therapeutics
    M. M.
    Chief Scientific Officer
  • Chief Business Officer at Nucleome Therapeutics
    B. H.
    Chief Business Officer
  • Chief People Officer at Nucleome Therapeutics
    S. M.
    Chief People Officer
  • Vice President Computational Biology at Nucleome Therapeutics
    R. R.
    Vice President Computational Biology
  • Vp Finance at Nucleome Therapeutics
    E. M. F.
    Vp Finance

Nucleome Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Business
  • Consulting
  • Entrepreneurship
  • Engineering
  • Other
  • Human Resources
  • Sales

Biotechnology is the largest department at 53% of profiles with a known department, followed by Entrepreneurship (11%) and Consulting (8%).

Contact profiles from Nucleome Therapeutics

Name
Title
Contact
Location
Last Update
  • Chief Technology Officer at Nucleome Therapeutics
    J. W.
    Chief Technology Officer
    United Kingdom, England
    Oct 19, 2026
  • Chief Scientific Officer at Nucleome Therapeutics
    M. M.
    Chief Scientific Officer
    United Kingdom, England
    Sep 03, 2026
  • Chief Executive Officer at Nucleome Therapeutics
    M. B.
    Chief Executive Officer
    United Kingdom, England
    Sep 22, 2026
  • Chief Business Officer at Nucleome Therapeutics
    B. H.
    Chief Business Officer
    United Kingdom, England
    Jun 29, 2026
  • Chief People Officer at Nucleome Therapeutics
    S. M.
    Chief People Officer
    United Kingdom, England
    Sep 22, 2026
  • Co-Founder And Consultant at Nucleome Therapeutics
    J. D.
    Co-Founder And Consultant
    United Kingdom, England
    Sep 20, 2026
  • Vice President Computational Biology at Nucleome Therapeutics
    R. R.
    Vice President Computational Biology
    United Kingdom
    Oct 15, 2026
  • Vp, Functional Genomics at Nucleome Therapeutics
    J. H.
    Vp, Functional Genomics
    United Kingdom, England
    Oct 15, 2026
  • Vp Finance at Nucleome Therapeutics
    E. M. F.
    Vp Finance
    United Kingdom, England
    Oct 15, 2026
  • Financial Controller at Nucleome Therapeutics
    A. M. R.
    Financial Controller
    United Kingdom, England
    Oct 15, 2026

Frequently Asked Questions

What are the largest departments at Nucleome Therapeutics?

Minus sign iconPlus sign icon
Biotechnology is the largest department at 53% of profiles with a known department, followed by Entrepreneurship (11%) and Consulting (8%). Nucleome Therapeutics's workforce spans 11 departments.

Where are Nucleome Therapeutics's employees located?

Minus sign iconPlus sign icon
Nucleome Therapeutics has about 54 employees across 2 continents, most of them in Europe. Europe accounts for 98% of Nucleome Therapeutics's workforce, followed by North America (2%). By country, the largest groups are United Kingdom Of Great Britain And Northern Ireland (92%), Netherlands (4%) and Spain (2%).

How many employees does Nucleome Therapeutics have currently?

Minus sign iconPlus sign icon
Nucleome Therapeutics has approximately 54 employees as of October 2026. These team members are located across 2 continents, including Europe and North America.

Who are Nucleome Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of October 2026, Nucleome Therapeutics's key employees include:

  • Chief Executive Officer: M. B.
  • Cso At Nucleome Therapeutics: S. H.
  • Chief Technology Officer: J. W.
  • Chief Scientific Officer: M. M.
  • Chief Business Officer: B. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

What is Nucleome Therapeutics's most common email format?

Minus sign iconPlus sign icon
Nucleome Therapeutics employees' email format typically follows the pattern of First.Last@nucleome.com. Trying to find reliable and up-to-date employee contact data? Find more Nucleome Therapeutics email formats with LeadIQ.

What is Nucleome Therapeutics known for?

Minus sign iconPlus sign icon
Nucleome Therapeutics was founded in 2019 and operates in the Biotechnology Research industry. Explore Nucleome Therapeutics's company overview page for more information.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.